Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV L-citrulline in steady-state sickle cell disease
NCT02314689Phase 1Completed
- Start
- Jan 2015
- Primary completion
- Dec 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label trial of citrulline in sickle cell disease (SCD). Primary endpoint: Number of Participants With Grade 2 or Higher Adverse Event According to NCI Criteria at 12 months. Started Jan 2015; status: completed.
02
Drugs
citrulline
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT02314689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02314689.